Deuteria Pharmaceuticals

• Emerging early stage pharmaceutical company
• Focus on deuterium-enriched therapeutic drugs
• Advancing compounds from discovery to Phase IIa (Proof-of-concept)
• Privately funded

Potential Benefits of Deuterium-Enriched Therapeutics

• Naturally occurring element that results in more stable compounds
• Improved product profile
• Expedited development path based on known commercial drugs
• Within industry, at least six Phase 1/2 trials have demonstrated medicinal benefits
• Scalable & commercially viable manufacturing